MARC record from Internet Archive

LEADER: 05813cam 2200913 a 4500
001 ocm40120396
003 OCoLC
005 20200514000126.0
008 981007s1999 sz a b 001 0 eng
010 $a 98043240
040 $aDNLM/DLC$beng$cDLC$dNLM$dC#P$dOHX$dUKM$dBAKER$dBTCTA$dYDXCP$dSZ9XM$dZWZ$dOCLCQ$dOCLCO$dNAM$dUKMGB$dOCLCQ$dOCLCO$dOCLCA$dOCLCF$dOCLCA$dCUY
015 $aGBA001976$2bnb
016 7 $a9825995$2DNLM
016 7 $a006509857$2Uk
019 $a123071156
020 $a380556791X$q(hardcover)
020 $a9783805567916$q(hardcover)
035 $a(OCoLC)40120396$z(OCoLC)123071156
043 $ae-sz---
050 00 $aRC568.H4$bU25 1999
060 00 $a2000 A-041
060 10 $aWM 288$bP933 1999
072 7 $aRC$2lcco
082 00 $a616.86/32061$221
245 00 $aPrescription of narcotics for heroin addicts :$bmain results of the Swiss national cohort study /$cA. Uchtenhagen [and others].
260 $aBasel ;$aNew York :$bKarger,$c℗♭1999.
300 $aviii, 134 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aMedical prescription of narcotics ;$vvol. 1
504 $aIncludes bibliographical references and index.
505 0 $a1. Programme Objectives -- 2. Research Topics and Research Plan -- 3. Research Organisation -- 4. Presentation of Findings -- 4.1. Substance-Related Findings -- 4.1.1. Dosages and Substance Combinations -- 4.1.2. Pharmacology: Pharmacodynamics and Pharmacokinetics -- 4.1.3. Toxicology: Side-Effects -- 4.1.4. Summary of Randomised and Double-Blind Studies -- 4.1.5. Therapeutic Suitability of Substances and Methods of Administration -- 4.1.6. Open Questions -- 4.2. Patient-Related Results -- 4.2.1. Samples -- 4.2.2. Characteristics of Patients -- 4.2.3. Retention Rate -- 4.2.4. Changes in Health Status -- 4.2.5. Changes in Addictive and Risk Behaviour -- 4.2.6. Changes in Social Integration -- 4.2.7. Changes in Criminal Behaviour -- 4.2.8. Terminations and Subsequent Treatments -- 4.2.9. Deaths -- 4.2.10. Limitations of Findings -- 4.3. Service-Related Results -- 4.3.1. Implementation of Treatment Centres -- 4.3.2. Security Aspects -- 4.3.3. Integration of Narcotics Prescription Into Polyvalent Out-Patient Clinics -- 4.3.4. Integration of Narcotics Prescription Into a Penal Institution -- 4.3.5. Costs and Funding -- 4.3.6. A Cost-Benefit Analysis -- 4.3.7. Neighbourhood and Political Environment -- 4.3.8. Limitations of Findings -- 5. Evaluation of the Results -- 5.1. Research Design and Methodology -- 5.2. Outcome Criteria -- 5.3. Comparative Analysis of Findings from PROVE. from Residential Drug-Free Treatments and from Substitution Treatments Using Oral Methadone -- 5.4. Limitations of Study -- 6. Conclusions and Recommendations -- 6.1. Indication for Heroin-Assisted Treatment -- 6.2. Carrying Out Heroin-Assisted Treatment -- 6.3. Control Measures for Heroin-Assisted Treatment -- 6.4. Final Recommendation -- Postscript: Political Decisions and the Future of Heroin-Assisted Treatment in Switzerland.
540 $aCurrent copyright fee: GBP36.40$c24\0.$5Uk
650 0 $aHeroin abuse$zTreatment$zSwitzerland.
650 0 $aNarcotics$xTherapeutic use.
650 0 $aDrug abuse$xTreatment$zSwitzerland.
650 0 $aDrug addicts$xRehabilitation$zSwitzerland.
650 12 $aHeroin Dependence$xdrug therapy.
650 22 $aEvaluation Studies as Topic.
650 22 $aNarcotics$xtherapeutic use.
650 22 $aSubstance Abuse Treatment Centers.
651 2 $aSwitzerland.
650 7 $aDrug abuse$xTreatment.$2fast$0(OCoLC)fst00898588
650 7 $aDrug addicts$xRehabilitation.$2fast$0(OCoLC)fst01430276
650 7 $aHeroin abuse.$2fast$0(OCoLC)fst01430477
650 7 $aNarcotics$xTherapeutic use.$2fast$0(OCoLC)fst01032874
651 7 $aSwitzerland.$2fast$0(OCoLC)fst01205401
650 17 $aDe pendance a l'he roi ne$xTraitement me dicamenteux.$2fmesh
650 27 $aCentre de traitement de la toxicomanie$xSuisse.$2fmesh
650 27 $aStupe fiants$xusage the rapeutique.$2fmesh
650 7 $aE tudes d'e valuation comme sujet$xSuisse.$2fmesh
650 7 $aDrogues$xEmploi en the rapeutique$zSuisse.$2ram
650 7 $aMe dicaments$xAbus$zSuisse.$2ram
650 7 $aHe roi nomanie$xThe rapeutique$zSuisse.$2ram
650 7 $aDrogenabha ngigkeit$xHeroin$xSubstitutionstherapie$xProjekt$xBewertung$zSchweiz.$2swd
650 7 $aHeroin$xDrogenabha ngigkeit$xSubstitutionstherapie$xProjekt$xBewertung$zSchweiz.$2swd
650 7 $aSubstitutionstherapie$xDrogenabha ngigkeit$xHeroin$xProjekt$xBewertung$zSchweiz.$2swd
651 7 $aSchweiz$xDrogenabha ngigkeit$xHeroin$xSubstitutionstherapie$xProjekt$xBewertung.$2swd
700 1 $aUchtenhagen, Ambros.
776 08 $iOnline version:$tPrescription of narcotics for heroin addicts.$dBasel ; New York : Karger, ℗♭1999$w(OCoLC)607216385
776 08 $iOnline version:$tPrescription of narcotics for heroin addicts.$dBasel ; New York : Karger, ℗♭1999$w(OCoLC)609319837
830 0 $aMedical prescription of narcotics ;$vvol. 1.
856 $31850-9999$uhttp://www.karger.com/$xBLDSS
938 $aBaker & Taylor$bBKTY$c50.50$d50.50$i380556791X$n0003225179$sactive
938 $aBaker and Taylor$bBTCP$n98043240
938 $aOtto Harrassowitz$bHARR$nhar005104561
938 $aYBP Library Services$bYANK$n1572045
029 1 $aAU@$b000014232092
029 1 $aAU@$b000021335595
029 1 $aAU@$b000023370123
029 1 $aNLGGC$b174791127
029 1 $aNLM$b9825995
029 1 $aOHX$bhar005104561
029 1 $aYDXCP$b1572045
029 1 $aZWZ$b046610766
029 1 $aUKMGB$b006509857
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 87 OTHER HOLDINGS